Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kaisi Kaidi Pharmaceutical Technology

Request full access

Innovative drugs targeting nuclear receptors and GPCRs for metabolic diseases, tumors, and inflammation

ChinaFounded 2017Biotech & Life Sciences

About Kaisi Kaidi Pharmaceutical Technology

Cascade, established in December 2017, is a Sino-foreign joint venture biomedical enterprise specializing in the development of innovative drugs targeting nuclear receptors and G protein-coupled receptors (GPCRs). The company's core research and development (R&D) team is led by internationally renowned structural biologists and top nuclear receptor scientists, boasting over 20 years of experience in innovative drug research. Cascade focuses on addressing critical health issues such as metabolic diseases, tumors, and inflammation through structure-based drug design. The company operates in the biomedical sector, primarily serving healthcare providers, pharmaceutical companies, and research institutions. Cascade's business model revolves around the discovery, development, and commercialization of novel therapeutic drugs. Revenue is generated through partnerships, licensing agreements, and direct sales of their proprietary drugs.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
20.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing Jun 2026 $44M $175M Taiping Healthcare Fund ↗
SERIES BOther financing Nov 2025 $41M $165M Zhangjiang Hi-Tech Park · River Head Capital · Fuho Capital · Lingang Blue Bay Fund ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Kaisi Kaidi Pharmaceutical Technology website traffic

Latest recorded traffic for Kaisi Kaidi Pharmaceutical Technology is 90 monthly website visits, down 75% over the last three months.

Latest monthly visits90 3-month web change-75%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Kaisi Kaidi Pharmaceutical Technology in its local ecosystem

Live from Dealroom

The Kaisi Kaidi Pharmaceutical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A11 investors entered at this stage

  • Puhua Capital
  • NNFE Fund Management
  • CAS Investment Management
  • Hyfinity Investments
  • Longpan Investment
  • Shanghai State Investment
  • Zhangjiang Hi-Tech Park
  • River Head Capital
  • Fuho Capital
  • Lingang Blue Bay Fund
  • Shanghai Pudong Venture Capital

Series B and later1 investor entered at this stage

  • Taiping Healthcare Fund
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Kaisi Kaidi Pharmaceutical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kaisi Kaidi Pharmaceutical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.